Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Megumi Wakisaka"'
Autor:
Ryungsa Kim, Ami Kawai, Megumi Wakisaka, Mika Shimoyama, Naomi Yasuda, Mitsuya Ito, Takanori Kin, Koji Arihiro
Publikováno v:
Cancer Reports, Vol 6, Iss 4, Pp n/a-n/a (2023)
Abstract Background and Aim Non‐invasive breast carcinoma is considered to be localized disease and is distinguished from invasive ductal and lobular carcinomas. The local recurrence of non‐invasive carcinoma after surgery may lead to development
Externí odkaz:
https://doaj.org/article/ccbd7805abfb4e68982a50e82afa5511
Autor:
Ryungsa Kim, Ami Kawai, Megumi Wakisaka, Mika Shimoyama, Naomi Yasuda, Takanori Kin, Koji Arihiro
Publikováno v:
Cancer Reports, Vol 6, Iss 1, Pp n/a-n/a (2023)
Abstract Background Recurrence after primary treatment is an important obstacle to the curing of primary breast cancer. Less‐immunosuppressive anesthetic techniques, such as local anesthesia with lidocaine, intravenous anesthesia (IVA) with propofo
Externí odkaz:
https://doaj.org/article/1d326579373c45fbbe9ee282fd713275
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
The relationship between the anesthetic technique and cancer recurrence has not yet been clarified in cancer surgery. Surgical stress and inhalation anesthesia suppress cell-mediated immunity (CMI), whereas intravenous (IV) anesthesia with propofol a
Externí odkaz:
https://doaj.org/article/c40c64bf63cf4c4081647fa5177fcb3a
Autor:
Ryungsa Kim, Ami Kawai, Megumi Wakisaka, Sayaka Sawada, Mika Shimoyama, Naomi Yasuda, Masayuki Hidaka, Yukitaka Morita, Shoichiro Ohtani, Mitsuya Ito, Kensuke Kawasaki, Takanori Kin, Koji Arihiro
Publikováno v:
Translational Oncology, Vol 14, Iss 1, Pp 100927- (2021)
Immune activation plays an important role in achieving the pathological and therapeutic effects of preoperative chemotherapy in patients with breast cancer. We evaluated how the immune response contributes to various therapeutic effects. This study w
Externí odkaz:
https://doaj.org/article/e7682bb98d63462684d461968eb0c2dc
Autor:
Ryungsa Kim, Ami Kawai, Megumi Wakisaka, Yuri Funaoka, Shoichiro Ohtani, Mitsuya Ito, Takayuki Kadoya, Morihito Okada
Publikováno v:
Clinical and Translational Medicine, Vol 6, Iss 1, Pp 1-8 (2017)
Abstract Background Surgery/anesthetic technique-stimulated immunosuppression may be associated with outcome for cancer patients. Here, the immune responses of patients undergoing day surgery versus hospitalization surgery for breast cancer were comp
Externí odkaz:
https://doaj.org/article/5fea009d230646a396c3062d09eb7f6f
Autor:
Ryungsa Kim, Ami Kawai, Megumi Wakisaka, Mika Shimoyama, Naomi Yasuda, Mitsuya Ito, Takanori Kin, Koji Arihiro
Publikováno v:
Cancer Reports. 6
Non-invasive breast carcinoma is considered to be localized disease and is distinguished from invasive ductal and lobular carcinomas. The local recurrence of non-invasive carcinoma after surgery may lead to development of invasive carcinoma and promo
Autor:
Yukitaka Morita, Mika Shimoyama, Sayaka Sawada, Masayuki Hidaka, Koji Arihiro, Shoichiro Ohtani, Ami Kawai, Megumi Wakisaka, Naomi Yasuda, Ryungsa Kim
Publikováno v:
European Journal of Surgical Oncology. 46:77-84
Purpose To evaluate immune responses paralleling the pathological and therapeutic effects of neoadjuvant chemotherapy (NAC) in the tumor microenvironment of breast cancer. Patients and Methods 38 patients with stages II and III breast cancer received
Autor:
Ryungsa Kim, Ami Kawai, Megumi Wakisaka, Mika Shimoyama, Naomi Yasuda, Takanori Kin, Koji Arihiro
Publikováno v:
Cancer reports (Hoboken, N.J.)REFERENCES.
Recurrence after primary treatment is an important obstacle to the curing of primary breast cancer. Less-immunosuppressive anesthetic techniques, such as local anesthesia with lidocaine, intravenous anesthesia (IVA) with propofol, and/or sedation wit
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
The relationship between the anesthetic technique and cancer recurrence has not yet been clarified in cancer surgery. Surgical stress and inhalation anesthesia suppress cell-mediated immunity (CMI), whereas intravenous (IV) anesthesia with propofol a
Autor:
Masayuki Hidaka, Shoichro Ohtani, Ryungsa Kim, Megumi Wakisaka, Koji Arihiro, Ami Kawai, Mitsuya Ito, Naomi Yasuda, Yuri Funaoka, Yukitaka Morita
Publikováno v:
Cancer Immunology, Immunotherapy. 68:577-585
Tumor-infiltrating lymphocytes are an important prognostic factor after neoadjuvant chemotherapy (NAC) in patients with breast cancer. Natural killer (NK) cells play critical roles in antitumor immune surveillance. Here, we assessed the relationship